Profilo
Andrew Marsh worked as the Head of Clinical Development at Ra Pharmaceuticals, Inc. and later as the Head of Development Operations at Synlogic, Inc. He completed his undergraduate degree at Boston University.
Precedenti posizioni note di Andrew Marsh
| Società | Posizione | Fine |
|---|---|---|
| SYNLOGIC, INC. | Corporate Officer/Principal | 01/05/2021 |
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Andrew Marsh
| Boston University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SYNLOGIC, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Andrew Marsh
